Sirtex Medical is not FDA approved for HCC which this study was on.
Looks like they will get a new FDA label to HCC but will have to wait for the results from SIRveNIB study on the 6th June and the subgroup analysis.
Many people speculated that the SARAH study, reported today, was going to miss it's primary endpoint as the group of patients was too mixed.
The FOXFIRE and SIRveNIB study results will most likely have hits on success for their primary endpoints.
- Forums
- ASX - By Stock
- SRX
- Sirt result
Sirt result, page-4
-
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
15.3¢ |
Change
-0.003(1.61%) |
Mkt cap ! $64.72M |
Open | High | Low | Value | Volume |
15.0¢ | 15.5¢ | 15.0¢ | $58.98K | 380.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 2627800 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 80934 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 2627800 | 0.150 |
4 | 991379 | 0.145 |
1 | 60000 | 0.140 |
1 | 153846 | 0.130 |
2 | 247900 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 7212 | 2 |
0.160 | 2398783 | 19 |
0.165 | 296786 | 10 |
0.170 | 99369 | 3 |
0.175 | 265000 | 2 |
Last trade - 15.59pm 10/07/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online